Diabetes drugs offered fresh start (Nature News, 21 July 2010)

21 Jul 2010


A paper in the journal Nature discusses ways in which new drugs may be developed for the treatment of type 2 diabetes in obese people, following the recent implications of an increased risk of heart-attack with Avandia (generic name rosiglitazone).

Full article


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story